Palliative care and end of life management in patients with idiopathic pulmonary fibrosis
Keywords:
End of life, palliative care, health-related quality of life, idiopathic pulmonary fibrosisAbstract
Idiopathic pulmonary fibrosis (IPF) is a chronic disease with an unknown etiology that causes deterioration of the structure of the lung parenchyma, resulting in a severe and progressive decline in respiratory function and early mortality. IPF is essentially an incurable disease, with a mean overall survival of 5 years in approximately 20% of patients without treatment. The combination of a poor prognosis, uncertainty about the disease's progression, and the severity of symptoms has a significant impact on the quality of life of patients and their families. New antifibrotic drugs have been shown to slow disease progression, but their impact on health-related quality of life (HRQoL) has to be proven yet. To date, studies have shown that palliative care can improve symptom management, HRQoL, and end-of-life care (EoL) in patients with IPF, reducing critical events, hospitalization, and health costs. As a result, it is essential for proper health planning and patient management to establish palliative care early and in conjunction with other therapies, beginning with the initial diagnosis of the disease.
References
Kreuter M, Bendstrup E, Russell AM, Bajwah S, Lindell K, Adir Y, et al. Palliative care in interstitial lung disease: living well. Lancet Respir Med 2017;5:968-80.
De Vries J, Kessels BLJ, Drent M. Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J 2001;17:954-61.
World Health Organization. Palliative care. Accessed 1 June 2017. Available from: http://www.who.int/cancer/palliative/definition/en/
Sallnow L, Smith R, Ahmedzai S H, Bhadelia A, Chamberlain C, Cong Y, et al. Report of the Lancet Commission on the Value of Death: bringing death back into life. Lancet 2022;399:837-84.
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
Bonella F, Wijsenbeek M, Molina-Molina M, Duck A, Mele R, Geissler K, et al. European IPF patient charter: unmet needs and a call to action for healthcare policymakers. Eur Respir J 2016;7:597-606.
Younus S, Bakal JA, Richman-Eisenstat J, Alrehaili G, Aldhaheri S, Morales M, et al. Comparison of palliative care models in idiopathic pulmonary fibrosis. Appl Sci 2021;11:9028.
Lindell KO, Liang Z, Hoffman LA, Rosenzweig MQ, Saul MI, Pilewski JM, et al. Palliative care and location of death in decedents with idiopathic pulmonary fibrosis. Chest 2015;147:423-9.
Kalluri M, Orenstein S, Archibald N, Pooler C. Advance care planning needs in idiopathic pulmonary fibrosis: A qualitative study. Am J Hosp Palliat Care 2022;39:641-51.
Bajwah S, Yorke J. Palliative care and interstitial lung disease. Curr Opin Support Palliat Care 2017;11:141-6.
Veigh CM, Reid J, Larkin P, Porter S, Hudson P. The provision of generalist and specialist palliative care for patients with nonmalignant respiratory disease in the North and Republic of Ireland: a qualitative study. BMC Palliat Care 2018;17:6.
Sobanski PZ, Alt-Epping B, Currow DC, Goodlin SJ, Grodzicki T, Hogg K, et al, Palliative care for people living with heart failure: European Association for Palliative Care Task Force expert position statement. Cardiovas Res 2020;116:12-27.
Magnani C, Peruselli C, Tanzi S, Bastianello S, Bonesi MG, Moroni L, et al. Complessità e cure palliative. Riv it Cure Palliative 2019;21:196-204.
Ministero della Salute. Accordo, ai sensi dell’articolo 4, comma 1, del decreto legislativo 28 agosto 1997, n. 281, sul documento “Accreditamento delle reti di cure palliative, ai sensi della Legge 15 marzo 2010 n. 38”. Conferenza Stato-Regioni Rep. Atti n. 118/CSR del 27 luglio 2020. Available from: https://www.salute.gov.it/imgs/C_17_pubblicazioni_3046_allegato.pdf
Ministero della Salute. Norme in materia di consenso informato e di disposizioni anticipate di trattamento. Legge 22 dicembre 2017, n. 219 (18G00006) (GU Serie Generale n.12 del 16-01-2018) note: Entrata in vigore del provvedimento: 31/01/2018. Available from: https://www.trovanorme.salute.gov.it/norme/dettaglioAtto?id=62663
Micco M, Di Sorbo A, Del Donno M. End of life of patients with idiopathic pulmonary fibrosis. In: A. M. Esquinas, N. Vargas, editors. Ventilatory support and oxygen therapy in elder, palliative and end-of-life care patients. Springer, Cham: 2020; p. 289-304.
Evangelista CB, Lopez MEL, Costa SF, Batista PS, Batista JB, Oliveira AM. Palliative care and spirituality: an integrative literature review. Rev Bras Enferm 2016;69:591-601.
Rajala K, Lehto JT, Saarinen M, Sutinen E, Saarto T, Myllärniemi M. End-of-life care of patients with idiopathic pulmonary fibrosis. BMC Palliat Care 2016;15:85.
Morata L. An evolutionary concept analysis of futility in health care. J Adv Nurs 2018;74:1289-300.
Mohammed S, Peter E. Rituals, death and the moral practice of medical futility. Nurs Ethics 2009;16:292-302.
Rinnenburger DE, Alma MG, Bigioni D, Brunetti G, Liberati C, Magliacani V, et al. End-of- life decision making in respiratory failure. The therapeutic choices in chronic respiratory failure in a 7-item questionnaire. Ann Ist Super Sanita 2012;48:328-33.
Società Italiana di Cure Palliative. Le cure di fine vita e l’anestesista-rianimatore”: raccomandazioni SIAARTI per l’approccio al morente. Update 2018. Available from: https://www.sicp.it/documenti/altri/2018/07/il-nuovo-documento-siaarti-sul-fine-vita/
Fadul N, Elsayem AF, Bruera E. Integration of palliative care into COVID-19 pandemic planning. BMJ Support Palliat Care 2021;11:40-4.
Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet 2020;395:1225-8.
Nardini S, Sanguinetti CM, De Benedetto F, Baccarani C, Del Donno M, Polverino M, et al. SARS-CoV-2 pandemic in Italy: ethical and organizational considerations. Multidiscip Respir Med 2020;15:672.
General Medical Council. Treatment and care towards the end of life: good practice in decision making. 20 May 2010. Available from: https://www.gmc-uk.org/ethical-guidance/ethical-guidance-for-doctors/treatment-and-care-towards-the-end-of-life
Canadian Hospice Palliative Care Association. A Model to Guide Hospice Palliative Care, Available from: https://www.chpca.ca/wp-content/uploads/2019/12/norms-of-practice-eng-web.pdf
Rome RB, Luminais HH, Bourgeois DA, Blais CM. The role of palliative care at the end of life. Ochsner J 2011;11:348-52.
Abernethy AP, Aziz NM, Basch E, Bull J, Cleeland CS, Currow DC, et al. a strategy to advance the evidence base in palliative medicine: Formation of a palliative care research cooperative group. J Palliat Med 2010;13:1407-13.
van Manen MJ, Geelhoed JJ, Tak NC, Wijsenbeek MS. Optimizing quality of life in patients with idiopathic pulmonary fibrosis. Ther Adv Respir Dis 2017;11:157-69. Erratum in: Ther Adv Respir Dis 2017;11:245.
Ferrara G, Luppi F, Birring SS, Cerri S, Caminati A, Sköld M, et al. Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions. Eur Respir Rev 2018;27:170076.
Bajwah S, Yorke J. Palliative care and interstitial lung disease. Curr Opin Support Palliat Care 2017;11:141-6.
Ryerson CJ, Donesky D, Pantilat SZ, Collard HR. Dyspnea in idiopathic pulmonary fibrosis: a systematic review. J Pain Symptom Manag 2012;43:771-82.
Bajwah S. Specialist palliative care is more than drugs: a retrospective study of ILD patients. Lung 2012;190:215-20.
Gallagher R. The use of opioids for dyspnea in advanced disease. CMAJ 2011;183:1170.
Clemens KE, Quednau I, Klaschik E. Is there a higher risk of respiratory depression in opioid naive palliative care patients during symptomatic therapy of dyspnea with strong opioids? J Palliat Med 2008;11:204-16.
Ahmadi Z, Wysham NG, Lundström S, Janson C, Currow DC, Ekström M. End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study. Thorax 2016;71:510-6.
Lindell KO, Olshansky E, Song MK, Song MK, Zullo TG, Gibson KF, Kaminski N, et al. Impact of a disease-management program on symptom burden and health related quality of life in patients with idiopathic pulmonary fibrosis and their care partners. Heart Lung 2010;39:304-13.
van Manen MJG, Birring SS, Vancheri C, Cottin V, Renzoni EA, Russell AM, et al. Cough in idiopathic pulmonary fibrosis. Eur Respir Rev 2016; 25:278-86.
van Manen MJG, Birring SS, Vancheri C, Vindigni V, Renzoni E, Russell AM, et al. Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis. Eur Respir J 2017;50:701157.
Ryerson CJ, Cayou C, Topp F, Hilling L, Camp PG, Wilcox PG, et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med 2014;108:203-10.
Gaudry S, Vincent F, Rabbat A, Nunes H, Crestani B, Naccache JM, et al. Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia. J Thorac Cardiovasc Surg 2014;147:47-53.
Lightowler JV, Fau WJ, Fau EM, Ram FS. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ 2003;326:185.
Rush B, Wiskar K, Berger L, Griesdale D. The use of mechanical ventilation in patients with idiopathic pulmonary fibrosis in the United States: a nationwide retrospective cohort analysis. Respir Med 2016;111:72-6.
Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372:2185-96.
Steve GP, Steven RH, Gay PC. High-flow nasal cannula therapy in do-not-intubate patients with hypoxemic respiratory distress. Respir Care 2013;58:597-600.
Lee AS, Mira-Avendano I, Ryu JH, Daniels CE. The burden of idiopathic pulmonary fibrosis: an unmet public health need. Respir Med 2014;108:955-67.
Centro Coordinamento Malattie Rare Regione Campania. Percorso diagnostico terapeutico assistenziale PDTA-Regione Campania. Fibrosi polmonare idiopatica (RHG010). DCA 32 del 25.03.2019 della Regione Campania. Available from: http://www.ospedalideicolli.it/malattie-rare-campania/wp-content/uploads/sites/2/2021/01/Fibrosi-polmonare-idiopatica.pdf
Knaul FM, Farmer PE, Krakauer EL, De Lima L, Bhadelia A, Jiang Kwete X, et al. Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report. Lancet 2018;391:1391-454.
Published
Issue
Section
License
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Mattioli 1885 has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
How to Cite
